Persist AI
Developing long-lasting drug formulations 50% faster
Woodland, United States · Founded 2022 · $4.0M raised
- Headquarters
- Woodland
- Employees
- 1–10
- Founded
- 2022
- Website
- persist-ai.com
- Total Funding
- $4.0M
- Last Round
- $4.0M SeedAug 2023
- Rounds
- 1
About
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Summary
Persist AI is an Artificial Intelligence company based in Woodland, United States, founded in 2022. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Aug 2023. Investors include 2048 Ventures, Innospark Ventures and Fellows Fund.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2023
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
AI company focused on applying artificial intelligence to physical tasks, launched with $6.2B ini...
Self-driving cars.
China's leading blood products manufacturer
Shield AI's mission is to protect service members and innocent civilians with artificially intell...
Global contract research organization providing comprehensive drug development and laboratory ser...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/persist-ai"><img src="https://indexed.vc/api/badge/company/persist-ai" alt="Persist AI on Indexed.vc" width="260" height="76" /></a>